Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk.
Nivison-Smith, Ian
Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk. [electronic resource] - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Feb 2012 - 302-8 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
1523-6536
10.1016/j.bbmt.2011.05.003 doi
Adolescent
Adult
Age Factors
Aged
Australia--epidemiology
Chronic Disease
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
New Zealand--epidemiology
Primary Myelofibrosis--mortality
Registries
Retrospective Studies
Risk Factors
Survival Rate
Time Factors
Transplantation Conditioning--adverse effects
Transplantation, Homologous
Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk. [electronic resource] - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Feb 2012 - 302-8 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
1523-6536
10.1016/j.bbmt.2011.05.003 doi
Adolescent
Adult
Age Factors
Aged
Australia--epidemiology
Chronic Disease
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
New Zealand--epidemiology
Primary Myelofibrosis--mortality
Registries
Retrospective Studies
Risk Factors
Survival Rate
Time Factors
Transplantation Conditioning--adverse effects
Transplantation, Homologous